Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
Project Foresee: The Path to Cure CMT4C
…research on a CMT4C Gene Therapy solution dates back to 2018, with the first research papers published in March of 2019 (see Gene replacement therapy in a model of Charcot-Marie-Tooth…
CMTA Appoints David Skarinsky to its Therapy Expert Board
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research that’s aimed at bringing treatments and a cure to patients of this rare disease, is pleased to…
CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO
…their work. The CMTA has invested $23.5 million in its Strategy to Accelerate Research (STAR) since it was implemented in 2008, making it the world’s largest funder of CMT research….
Understanding Charcot-Marie-Tooth Disease in Children
This CMT awareness month, the CMTA’s Chief Research Officer, Katherine Forsey, PhD, shares her perspective as a CMT mum and how she navigated her own child’s participation in CMT research….
Type 1 CMT Gene Therapy Project Now Underway
…Accelerate Research (STAR) brings top researchers together with pharmaceutical and biotechnology partners to accelerate scientific breakthroughs. STAR has one goal: to accelerate the development of treatments for CMT. Both research…
CMTAfall2022web
CMTAfall2022web
2021 CMTA Annual Report
Ways to Give
FUND CMT RESEARCH The Strategy to Accelerate Research (STAR) incorporates a strategic approach to funding cutting edge research. LEARN MORE ABOUT GIVING TO CUTTING EDGE RESEARCH Be part of the…